SCHEDULE 13G/A: PNC Financial Services Group Discloses 5.39% Beneficial Stake in Eli Lilly and Company

The PNC Financial Services Group, Inc. has disclosed a beneficial ownership of 5.39% of Eli Lilly and Company's common stock, primarily through its role as a directed trustee for the Eli Lilly and Company Compensation Trust.

Summary

• The PNC Financial Services Group, Inc. (PNC) reported beneficial ownership of 51,153,837 shares of Eli Lilly and Company common stock as of December 31, 2024.
• This aggregate amount represents 5.39% of Eli Lilly and Company's common stock.
• The majority of these shares, specifically 50,000,000 shares (5.26% of the class), are held in the Eli Lilly and Company Compensation Trust account, for which PNC Bank, National Association serves as a directed trustee.
• PNC Bank, National Association shares both voting power and investment discretion with respect to these 50,000,000 shares.
• Additional shares are held in fiduciary capacities for clients outside the aforementioned trust by PNC Bank (1,111,517 shares), PNC Delaware Trust Company (25,389 shares), PNC Ohio Trust Company (1,226 shares), and PNC Investments LLC (15,705 shares).
• PNC certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Eli Lilly and Company.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing (Schedule 13G) disclosing beneficial ownership. It contains factual information about shareholdings and does not convey positive or negative sentiment regarding the issuer's performance or outlook.

Positives

• Demonstrates a significant, stable institutional holding in Eli Lilly and Company, primarily through a compensation trust, indicating long-term employee benefit alignment.
• The filing confirms that the shares are held in the ordinary course of business and not for control purposes, suggesting stability in the ownership structure.

Negatives

• NA

Risks

• The inclusion of the reporting persons and such securities in this report shall not be deemed an admission of beneficial ownership by the reporting persons for the purposes of Section 13(d) or 13(g) of the Act, or for any other purposes.

Future Outlook

NA

Management Comments

• The securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing is a standard regulatory disclosure for large institutional investors or parent holding companies that cross a 5% beneficial ownership threshold in a public company. It highlights the role of financial institutions like PNC in managing significant equity stakes, often on behalf of trusts or various client accounts, rather than for active investment or control purposes. For Eli Lilly, it signifies a stable, albeit passive, institutional ownership component.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• PNC Bank, National Association serves as directed trustee for the Eli Lilly and Company Compensation Trust account, holding 50,000,000 shares (5.26% of the class) of Eli Lilly and Company common stock.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder, confirming a large, passive stake primarily for employee compensation purposes.
• Employees (of Eli Lilly): The significant holding in the Eli Lilly and Company Compensation Trust directly impacts employees who are beneficiaries of this trust, linking their long-term compensation to the company's stock performance.

Next Steps

• NA

Key Dates

Keywords

Eli Lilly, PNC Financial Services Group, Schedule 13G, beneficial ownership, common stock, institutional investor, trust, financial services, pharmaceutical